De novo production of the flavonoid naringenin in engineered Saccharomyces cerevisiae

被引:263
|
作者
Koopman, Frank [1 ,2 ,3 ]
Beekwilder, Jules [2 ,4 ,5 ]
Crimi, Barbara [1 ,2 ,3 ]
van Houwelingen, Adele [4 ]
Hall, Robert D. [2 ,4 ,5 ]
Bosch, Dirk [2 ,4 ,5 ]
van Maris, Antonius J. A. [1 ,3 ]
Pronk, Jack T. [1 ,2 ,3 ]
Daran, Jean-Marc [1 ,2 ,3 ]
机构
[1] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands
[2] Platform Green Synthet Biol, NL-2600 GA Delft, Netherlands
[3] Kluyver Ctr Genom Ind Fermentat, NL-2600 GA Delft, Netherlands
[4] Plant Res Int, NL-6700 AA Wageningen, Netherlands
[5] Ctr Biosyst Genom, NL-6700 AB Wageningen, Netherlands
关键词
Saccharomyces cerevisiae; Naringenin; de novo; Flavonoids; Metabolic engineering; TYROSINE AMMONIA-LYASE; ESCHERICHIA-COLI; IN-VIVO; BIOSYNTHESIS; YEAST; EXPRESSION; ARABIDOPSIS; GENE; PATHWAY; GENOME;
D O I
10.1186/1475-2859-11-155
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Flavonoids comprise a large family of secondary plant metabolic intermediates that exhibit a wide variety of antioxidant and human health-related properties. Plant production of flavonoids is limited by the low productivity and the complexity of the recovered flavonoids. Thus to overcome these limitations, metabolic engineering of specific pathway in microbial systems have been envisaged to produce high quantity of a single molecules. Result: Saccharomyces cerevisiae was engineered to produce the key intermediate flavonoid, naringenin, solely from glucose. For this, specific naringenin biosynthesis genes from Arabidopsis thaliana were selected by comparative expression profiling and introduced in S. cerevisiae. The sole expression of these A. thaliana genes yielded low extracellular naringenin concentrations (<5.5 mu M). To optimize naringenin titers, a yeast chassis strain was developed. Synthesis of aromatic amino acids was deregulated by alleviating feedback inhibition of 3-deoxy-d-arabinose-heptulosonate-7-phosphate synthase (Aro3, Aro4) and byproduct formation was reduced by eliminating phenylpyruvate decarboxylase (Aro10, Pdc5, Pdc6). Together with an increased copy number of the chalcone synthase gene and expression of a heterologous tyrosine ammonia lyase, these modifications resulted in a 40 fold increase of extracellular naringenin titers (to approximately 200 mu M) in glucose-grown shake flask cultures. In aerated, pH controlled batch reactors, extracellular naringenin concentrations of over 400 mu M were reached. Conclusion: The results reported in this study demonstrate that S. cerevisiae is capable of de novo production of naringenin by coexpressing the naringenin production genes from A. thaliana and optimization of the flux towards the naringenin pathway. The engineered yeast naringenin production host provides a metabolic chassis for production of a wide range of flavonoids and exploration of their biological functions.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] De Novo High-Titer Production of Delta-Tocotrienol in Recombinant Saccharomyces cerevisiae
    Sun, Hong
    Yang, Jingli
    Lin, Xue
    Li, Congfa
    He, Yongjin
    Cai, Zhigang
    Zhang, Guoyin
    Song, Hao
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2020, 68 (29) : 7710 - 7717
  • [32] Metabolic engineering of Saccharomyces cerevisiae for itaconic acid production
    Blazeck, John
    Miller, Jarrett
    Pan, Anny
    Gengler, Jon
    Holden, Clinton
    Jamoussi, Mariam
    Alper, Hal S.
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2014, 98 (19) : 8155 - 8164
  • [33] Establishment of Saccharomyces cerevisiae as a cell factory for efficient de novo production of monogalactosyldiacylglycerol
    Gu, Xiaosong
    Shi, Yumei
    Luo, Changxin
    Cheng, Jintao
    BIOTECHNOLOGY FOR BIOFUELS AND BIOPRODUCTS, 2024, 17 (01):
  • [34] Engineering Saccharomyces cerevisiae for the de novo Production of Halogenated Tryptophan and Tryptamine Derivatives
    Milne, Nicholas
    Saez-Saez, Javier
    Nielsen, Annette Munch
    Dyekjaer, Jane Dannow
    Rago, Daniela
    Kristensen, Mette
    Wulff, Tune
    Borodina, Irina
    CHEMISTRYOPEN, 2023, 12 (04):
  • [35] Pathway elucidation of bioactive rhamnosylated ginsenosides in Panax ginseng and their de novo high-level production by engineered Saccharomyces cerevisiae
    Li, Chaojing
    Yan, Xing
    Xu, Zhenzhen
    Wang, Yan
    Shen, Xiao
    Zhang, Lei
    Zhou, Zhihua
    Wang, Pingping
    COMMUNICATIONS BIOLOGY, 2022, 5 (01)
  • [36] Growth-rate dependency of de novo resveratrol production in chemostat cultures of an engineered Saccharomyces cerevisiae strain
    Tim Vos
    Pilar de la Torre Cortés
    Walter M. van Gulik
    Jack T. Pronk
    Pascale Daran-Lapujade
    Microbial Cell Factories, 14
  • [37] Production of sesquiterpenoid zerumbone from metabolic engineered Saccharomyces cerevisiae
    Zhang, Chuanbo
    Liu, Jingjing
    Zhao, Fanglong
    Lu, Chunzhe
    Zhao, Guang-Rong
    Lu, Wenyu
    METABOLIC ENGINEERING, 2018, 49 : 28 - 35
  • [38] Production of Rebaudioside A from Stevioside Catalyzed by the Engineered Saccharomyces cerevisiae
    Li, Yan
    Li, Yangyang
    Wang, Yu
    Chen, Liangliang
    Yan, Ming
    Chen, Kequan
    Xu, Lin
    Ouyang, Pingkai
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2016, 178 (08) : 1586 - 1598
  • [39] High-Level Production of Hydroxytyrosol in Engineered Saccharomyces cerevisiae
    Liu, Huayi
    Wu, Xinxin
    Ma, He
    Li, Jian
    Liu, Zhenyu
    Guo, Xufan
    Dong, Jia
    Zou, Shaolan
    Luo, Yunzi
    ACS SYNTHETIC BIOLOGY, 2022, 11 (11): : 3706 - 3713
  • [40] De novo biosynthesis of carminic acid in Saccharomyces cerevisiae
    Zhang, Qian
    Wang, Xinglong
    Zeng, Weizhu
    Xu, Sha
    Li, Dong
    Yu, Shiqin
    Zhou, Jingwen
    METABOLIC ENGINEERING, 2023, 76 : 50 - 62